WO2008006486A1 - Préparations cosmétiques ou dermatologiques contenant de l'acide folique, des matières de charge et des épaississants - Google Patents

Préparations cosmétiques ou dermatologiques contenant de l'acide folique, des matières de charge et des épaississants Download PDF

Info

Publication number
WO2008006486A1
WO2008006486A1 PCT/EP2007/005871 EP2007005871W WO2008006486A1 WO 2008006486 A1 WO2008006486 A1 WO 2008006486A1 EP 2007005871 W EP2007005871 W EP 2007005871W WO 2008006486 A1 WO2008006486 A1 WO 2008006486A1
Authority
WO
WIPO (PCT)
Prior art keywords
fillers
preparations
cosmetic
weight
folic acid
Prior art date
Application number
PCT/EP2007/005871
Other languages
German (de)
English (en)
Inventor
Rixa Dippe
Anja Drucks
Julia Eckert
Christel Meding
Jens Nielsen
Jens Treu
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Priority to EP07765018A priority Critical patent/EP2046272A1/fr
Publication of WO2008006486A1 publication Critical patent/WO2008006486A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations

Definitions

  • Cosmetic or dermatological preparations containing folic acid, fillers and thickeners containing folic acid, fillers and thickeners
  • the present invention relates to cosmetic or dermatological preparations containing folic acid, fillers and thickeners.
  • the skin is exposed to a variety of environmental factors that can lead to their damage.
  • lipids and proteins especially the DNA is affected.
  • UVC region The damaging effect of the ultraviolet part of solar radiation on the skin is well known. While rays having a wavelength smaller than 290 nm (the so-called UVC region) are absorbed by the ozone layer in the earth's atmosphere, rays in the range between 290 nm and 320 nm, the so-called UVB region, cause erythema simple sunburn or even more or less severe burns.
  • UVA range it is important to have available filter substances, since its rays can cause reactions in photosensitive skin. It has been proven that UVA radiation leads to damage to the elastic and collagen fibers of the connective tissue, which the skin ages prematurely and that it can be seen as the cause of numerous phototoxic and photoallergic reactions. The damaging influence of UVB radiation can be amplified by UVA radiation.
  • DNA replication required in view of the large number of nucleotides that have to be copied per cell division is guaranteed, on the one hand, by the specificity of the DNA polymerases involved in replication (replicases) and, on the other hand, by their additional exonuclease activity: They catalyze the excision of inappropriate nucleotides and their replacement by the correct ones immediately after the new synthesis.
  • the damage caused by chemical action (by mutagens, some of which can intervene between two superimposed base pairs of the double helix) as well as the radiation-induced changes (eg two superimposed thymine residues can dimerize) help repair enzymes (including: Endonucleases, polymerases, ligases) that cut out and replace inappropriate nucleotides again from the DNA.
  • repair enzymes including: Endonucleases, polymerases, ligases
  • Some of these repair systems are inducible, i. H. they are synthesized only when needed. The question of which strand contains the original information and which was wrongly synthesized is apparently decided by the repair enzyme on the basis of the state of methylation.
  • Exposure to environmental influences causes damage to the DNA molecules of the cells of the body, which can, however, be remedied by cellular DNA repair mechanisms.
  • the DNA damage is detected and then the damage is repaired. If the damage is not completely eliminated shortly after it has been formed by repair processes, these accumulate in the form of permanent DNA damage in the cells and are subsequently passed on to the daughter cells.
  • This permanent damage in particular due to possible late effects (gradual loss of function), has a high potential for damage and is playing an increasingly important role in aging processes and in the initiation of damage already in childhood.
  • Object of the present invention was therefore to remedy the evils of the prior art remedy.
  • active ingredients and preparations should be provided which should ensure a reliable prophylaxis of damage to the skin's own DNA and / or in a particular embodiment should be used to repair damage already occurred to the skin's own DNA.
  • Folic acid has the following structure:
  • Folic acid occurs in liver, kidney, yeast, fungi, cereals and green leaves, predominantly as a conjugate with poly- ⁇ -L-glutamic acid (pteroylpolyglutamic acids). It has been discovered as a growth substance for various microorganisms and has a vitamin character for the human organism. Adult human needs are about 200 ⁇ g per day of bioavailable folate.
  • H 2 folate 7,8-dihydrofolic acid
  • FH 2 7,8-dihydrofolic acid
  • H 2 folate old abbreviation: FH 2
  • nicotinamide adenine dinucleotide phosphate and the enzyme dihydrofolate reductase.
  • H 2 folate in turn is produced in plants and some microorganisms via several intermediates of guanosine 5'-triphosphate (guanosine phosphates) and uses dihydrofolate reductase to convert (6S) -5,6,7,8-tetrahydrofolic acid, the actual physiologically active form of folic acid.
  • 7,8-Dihydrofolic acid has the following chemical structure:
  • derivatives of folic acid is to be understood in particular as meaning the abovementioned dihydrofolic acid and the tetrahydrofolic acid.
  • Folic acid-containing skin care products should be pleasant to use in addition to the positive effect on the skin. Powder raw materials give a pleasant silky velvet skin feeling. However, both folic acid (electrolyte) and powder raw materials destabilize an emulsion, so that the combination in an emulsion is often not storage and heat stable.
  • folic acid and / or derivatives thereof have a high potential for repairing damaged DNA. Furthermore, folic acid and / or its derivatives provide effective prophylaxis against DNA damage, especially those caused by UV radiation.
  • Fillers in the context of the present invention are particulate substances which as a rule do not produce any color effect in the cosmetic formulation in which they are used. Furthermore, fillers according to the invention usually have a low refractive index and, as a result, no or very little opacity.
  • fillers which z. B. serve as support materials in the formulation of powders or as viscosity and sensor modulators in emulsions or anhydrous formulations. Such fillers are also often used to obtain matting effects on the skin or to absorb sebum.
  • fillers generally also affects the spreadability of conventional formulations on the skin and the uniformity of a possible color effect.
  • the fillers in the context of the present invention are advantageously selected from the group of inorganic fillers, for example from the group of silicates.
  • Silicates are salts and esters (silicic acid esters) of orthosilicic acid [Si (OH) 4 ] and their condensation products.
  • the silicates are not only the most species-rich class of minerals, but also extremely important geologically and technically. Over 80% of the earth's crust is made up of silicates.
  • phyllosilicates are advantageous.
  • Layer silicates (phyllosilicates, leaf silicates) are (ideally) silicate structures with two-dimensionally infinite layers of [SiO 4 ] 4 ' tetrahedra, each tetrahedron being connected via 3 bridging oxygens with neighboring tetrahedra.
  • Chemical formulas can only be approximated for phyllosilicates because they have a large ion exchange capacity and silicon can be exchanged for aluminum and this in turn against magnesium, Fe 2+ , Fe 3+ , Zn and the like.
  • the resulting possibly negative charge of the layers is usually compensated by cations, in particular by Na + and Ca 2+ in interlayer positions.
  • Phyllosilicates can be obtained by reversible storage of water (in the 2- to 7-fold amount) and other substances such. As alcohols, glycols and the like swell. Their use as thickeners in cosmetic products is accordingly known per se. However, the prior art could not point the way to the present invention.
  • Advantageous phyllosilicates which can be used in the context of the present invention are, for example, those whose largest expansion direction in the unmodified and unswollen state has an average length of less than 10 ⁇ m.
  • the mean extents of the modified layered silicate particles used may be 1000 nm ⁇ 100 nm ⁇ 1 nm and less.
  • the effective size of the modified layered silicate particles in a cosmetic or dermatological formulation of course depends on the amount of stored substances.
  • Particularly advantageous (layered) silicates according to the invention are:
  • Kaolin Al 2 [Si 2 O 5 ] (OH) 4
  • Montmorillonite M + Al [Si 2 O 5 ] (OH), also called smectite. These include:
  • Bentonite montmorillonite with Ca (filler earth) or Na (Wyoming bentonite)
  • Mica an aluminosilicate that is easily fissile and is present in tabular crystals. Mica is transparent to translucent and has pearlescence. The most important form is muscovite: K Al 2 [AISi 3 O 10 ] (OH, F) 2 . Sericite is a special form of mica that has smaller platelets than muscovite. Magnesium silicate Mg 2 [Si 4 Oi 0 ] Also, silicon oxides (SiO 2 ) are to be used advantageously in the context of the present invention.
  • Aerosils (fumed silica), which are highly disperse silicas with frequently irregular shape, whose specific surface area is generally very large (200-400 m 2 / g) and which can be controlled by means of the production process, are preferred according to the invention. Aerosils are also referred to as: Amorphous Silica Amorphous Silicon Oxide Hydrate Silica, Amorphous Silicic Anhydride Silicon Dioxide Silicon Dioxide.
  • Aerosil 130 (Degussa Hüls), Aerosil 200 (Degussa Hüls), Aerosil 255 (Degussa Hüls), Aerosil 300 (Degussa Hellers), Aerosil 380 (Degussa Hellers), B-6C (Suzuki Yushi), CAB-O-SIL Fumed silica (Cabot), CAB-O-SIL EH-5 (Cabot), CAB-O-SIL HS-5 (Cabot), CAB-O-SIL LM-130 (Cabot), CAB-O-SIL MS-55 (Cabot), CAB-O-SIL M-5 (Cabot), E-6C (Suzuki Yushi), Fossil Flour MBK (MBK), MSS-500 (Kobo), Neosil CT 1 1 (Crosfield Co.), Ronasphere ( Rona / EM Industries), Silica, Anhydrous 31 (Whittaker, Clark & Daniels), Silica, Crystalline 216
  • Silicon oxides can also be produced in a spherical form, in which case the specific surface area is smaller than in the aerosils, since the particles are larger and round.
  • An example of this are the Ronaspheren (average particle diameter ⁇ 3 ⁇ ) from. Merck (see Figure 1).
  • Further fillers preferred according to the invention are silicas whose free OH groups on the particle surface are (completely or partially) organically modified.
  • Advantageous z the obtainable by addition of dimethylsilyl groups silica dimethyl silylates, such as Aerosil R972 (Degussa Hüls), Aerosil R974 (Degussa Hüls), CAB-O-SIL TS-610 (Cabot), CAB-O-SIL TS -720 (Cabot), Wacker HDK H15 (Wacker chemistry), Wacker HDK H18 (Wacker chemistry) and / or Wacker HDK H20 (Wacker chemistry).
  • dimethylsilyl groups silica dimethyl silylates such as Aerosil R972 (Degussa Hüls), Aerosil R974 (Degussa Hggs), CAB-O-SIL TS-610 (Cabot), CAB-O-SIL TS -720 (Cabot), Wacker HD
  • silicates obtainable by addition of trimethylsilyl groups (eg Aerosil R 812 (Degussa Hüls), CAB-O-SIL TS-530 (Cabot), Sipemat D 17 (Degussa Hüls), Wacker HDK H2000 (Wacker). Chemistry)).
  • trimethylsilyl groups eg Aerosil R 812 (Degussa Hüls), CAB-O-SIL TS-530 (Cabot), Sipemat D 17 (Degussa Hüls), Wacker HDK H2000 (Wacker). Chemistry
  • polymethylsilsesquioxanes obtainable by hydrolysis and condensation reactions of methyltrimethoxysilanes, which likewise have a round shape and whose particle size distribution can be controlled by the preparation.
  • Preferred polymethylsilsesquioxanes are available, for example, under the trade names Tospearl 2000 B from GE Bayer Silikones, Tospearl 145A from Toshiba, AEC Silicone Resin Spheres from A & E Connock and Wacker-Belsil PMS MK from Wacker-Chemie.
  • Boron nitride is isoelectronic with carbon (i.e., graphite and diamond shapes are possible). Boron nitride is characterized by its chemical inertness.
  • Wacker boron nitride BNP Wacker-Chemie Further advantageous fillers in the context of the present invention are carbonates, such as. As magnesium carbonate (MgCO 3 ) and calcium carbonate (CaCO 3 ). It is particularly advantageous for the purposes of the present invention to use the carbonates as fillers in dry powders.
  • MgCO 3 magnesium carbonate
  • CaCO 3 calcium carbonate
  • the fillers in the context of the present invention are also advantageously selected from the group of organic fillers.
  • advantageous organic fillers are, for.
  • natural polymers such as silk powder, microcrystalline cellulose and / or zinc stearates.
  • Advantageous organic fillers are also starch and starch derivatives, such as:
  • Organic fillers preferred according to the invention are also synthetic polymers, ie. H. Polymer particles which are present in the preparation in the form of solids, such as polycarbonates, polyethers, polyethylene, polypropylene, polyvinyl chloride, polystyrene, polyamides, polyurethanes, polyacrylates and the like. Particularly advantageous is z.
  • nylon polyamide 6 and polyamide 12
  • polyamide 6 for example microfine polyamide particles, in particular those available under the trade name SP-500 from TORAY.
  • polyamide 6- also: nylon 6
  • polyamide 12 also: nylon 1-2
  • Polyamide 6 is the polyamide [poly ( ⁇ -caprolactam)] synthesized from ⁇ -aminocaproic acid (6-aminohexanoic acid) or ⁇ -caprolactam
  • polyamide 12 is a poly ( ⁇ -laurinlactam) from ⁇ -laurolactam.
  • Advantageous in the sense of the present invention are, for example Orgasol ® 1002 (polyamide 6), and Orgasol ® 2002 (polyamide 12) from ELF ATOCHEM.
  • Silicone Resins Trimethylsiloxysilicate (eg SR 1000 GE Bayer Silicones)
  • silicone elastomers can be selected from the group of vinyl dimethicone crosspolymers, such as. Dow Corning 9506 Cosmetic Powder from Dow Coming (INCI: Dimethicone / Vinyl Dimethicone Crosspolymer).
  • silicone resins such as e.g. KSP-100, KSP-200 or KSP-300 from Shin Etsu, which are also listed under the INCI name Dimethicone / Vinyl Dimethicone Crosspolymer or SR 1000 from GE Bayer Silicones, which bears the INCI name Trimethylsiloxy Silicate
  • lauroyl lysine which is sold by Ajinomoto under the name Amihope LL.
  • the total amount of at least one filler in the finished cosmetic or dermatological preparations is advantageously selected from the range of 0.05-20.0% by weight, preferably 0.5-10.0% by weight, based on the total weight of the preparations.
  • Fillers preferred according to the invention come from the group of inorganic or organic silicon compounds.
  • the layer silicates are particularly preferred. Of these, kaolin, talc and mica are particularly preferred.
  • the preferred inorganic silicon compounds include the surface of the organically modified spherical particles.
  • Aerosil R 972 particularly preferred are the polymethylsilsesquioxanes and hydrophobically modified aerosils, e.g. Aerosil R 972.
  • Organic silicon compounds include the siloxane elastomers and siloxane resins. Of these, particularly preferred are the KSP types from Shin Etsu, as well as the trimethylsiloxysilicate.
  • fillers come from the group of spherical particles. More preferably, the average particle diameter is less than 20 microns. Furthermore, preference is given to choosing spherical particles of organic origin. Particularly preferred is the BPD-500 marketed by Kobo.
  • spherical particles having an average particle diameter of less than 10 ⁇ m are preferred.
  • nylon-12 e.g. sold as SP-501 or SP-500 by the company Kobo.
  • polymethyl methacrylates e.g. sold under the trade name Covabead LH 85 by LCW.
  • the preparations are characterized in that they contain 0.001% by weight to 10% by weight, preferably 0.05% by weight to 5% by weight, in particular 0.1-2, 0 wt .-%, based on the total weight of the preparations, on one or more fillers.
  • thickeners are preferably selected from the group of hydrocolloids.
  • Hydrocolloid is the technological abbreviation for the correct name.
  • Hydrocolloids are macromolecules that are largely linear in shape and have intermolecular interaction forces that allow side and major valence bonds between the individual molecules to form a reticulate structure that are partially water-soluble natural or synthetic polymers.
  • Forming gels or viscous solutions in aqueous systems they increase the viscosity of the water either by binding water molecules (hydration) or by taking up and enveloping the water in their interwoven macromolecules, while at the same time restricting the mobility of the water represent a large group of chemically very different natural and synthetic polymers whose common feature is their solubility in water or aqueous media, provided that these polymers have a solubility for water solubility have sufficient number of hydrophilic groups and are not too strongly crosslinked.
  • the hydrophilic groups may be nonionic, anionic or cati
  • the group of cosmetically and dermatologically relevant hydrocolloids can be classified as follows: organic, natural compounds, such as agar-agar, carrageenan, tragacanth,
  • Starch dextrins, gelatin, casein, organic, modified natural products such.
  • vinyl polymers polycarboxylic acids, polyethers, polyimines, polyamides, inorganic compounds such.
  • polysilicic acids clay minerals such as montmorillonites, zeolites, silicic acids.
  • Hydrocolloids which are preferred according to the invention are, for example, methylcelluloses, which are referred to as the methyl ethers of cellulose. They are characterized by the following structural formula
  • cellulose mixed ethers which are generally also referred to as methylcelluloses and, in addition to a dominating content of methyl, additionally contain 2-hydroxyethyl, 2-hydroxypropyl or 2-hydroxybutyl groups.
  • Particularly preferred are (hydroxypropyl) methylcelluloses, for example those available under the trade name Methocel E4M from Dow Chemical Comp.
  • sodium carboxymethylcellulose the sodium salt of the glycolic acid ether of cellulose, for which R in structural formula I can be a hydrogen and / or CH 2 -COONa.
  • Particularly preferred is sodium carboxymethylcellulose, also known as cellulose gum, available under the tradename Natrosol Plus 330 CS from Aqualon.
  • xanthan also called xanthan gum, which is an anionic heteropolysaccharide, which is generally formed by fermentation from corn sugar and isolated as the potassium salt. It is produced by Xanthomonas campestris and some other species under aerobic conditions with a molecular weight of 2 * 10 6 to 24 * 10 6 .
  • Xanthan comes with a chain ß-1, 4-bonded glucose (cellulose) formed with side chains. The structure of the subgroups consists of glucose, mannose, glucuronic acid, acetate and pyruvate.
  • Xanthan is the name given to the first microbial anionic heteropolysaccharide.
  • Xanthan is formed from a chain of ⁇ -1,4-linked glucose (cellulose) with side chains.
  • the structure of the subgroups consists of glucose, mannose, glucuronic acid, acetate and pyruvate.
  • the number of pyruvate units determines the viscosity of xanthan.
  • Xanthan is produced in two-day batch cultures with a yield of 70-90%, based on carbohydrate used. Yields of 25-30 g / l are achieved. The workup is carried out after killing the culture by precipitation with z.
  • B. 2-propanol. Xanthan is then dried and ground.
  • Advantageous gelling agent for the purposes of the present invention is also carrageenan, a gel-forming and similar to agar based extract of North Atlantic, to the Florideen counting red algae (Chondrus crispus and Gigartina stellata).
  • carrageenan is used for the dried algae product and carrageenan for the extract thereof.
  • the carrageenan precipitated from the hot-water extract of the algae is a colorless to sand-colored powder with a molecular weight range of 100,000-800,000 and a sulphate content of about 25%.
  • Carrageenan which dissolves very easily in warm water); Upon cooling, a thixotropic gel forms, even if the water content is 95-98%. The strength of the gel is effected by the double helix structure of the carrageenan.
  • Carrageenan has three main components:
  • the gel-forming ⁇ fraction consists of D-galactose-4-sulfate and 3,6-anhydro- ⁇ -D-galactose, which are alternately glycosidically linked in the 1, 3 and 1, 4 positions (Agar, in contrast, contains 3,6-anhydro- ⁇ -L-galactose).
  • the non-gelling ⁇ -fraction is composed of 1, 3-glycosidically linked D-galactose-2-sulfate and 1, 4-linked D-galactose-2,6-disulfate radicals u. easily soluble in cold water.
  • the ⁇ -carrageenan composed of D-galactose-4-sulfate in 1, 3-bond and 3,6-anhydro- ⁇ -D-galactose-2-sulfate in 1, 4-bond is both water-soluble and gel-forming.
  • Other types of carrageenan are also denoted by Greek letters: ⁇ , ⁇ , ⁇ , ⁇ , v, ⁇ , ⁇ , ⁇ , ⁇ .
  • the type of cations present K + , NH 4 + , Na + , Mg 2+ , Ca 2+ ) also influences the solubility of the carrageenans.
  • the use of chitosan in cosmetic preparations is known per se. Chitosan is a partially deacylated chitin.
  • X represents either the acetyl radical or hydrogen.
  • Chitosan is formed by deacetylation and partial depolymerization (hydrolysis) of chitin, which by the structural formula
  • chitosan In the range of about pH ⁇ 6 chitosan is positively charged and there also soluble in aqueous systems. It is not compatible with anionic raw materials. For this reason, the use of nonionic emulsifiers is suitable for producing chitosan-containing oil-in-water emulsions. These are known per se, for example from EP-A 776 657.
  • Preference according to the invention is given to chitosans having a degree of deacetylation of> 25%, in particular> 55 to 99% [determined by means of 1 H-NMR]).
  • chitosans with molecular weights between 10,000 and 1,000,000, especially those with molecular weights between 100,000 and 1,000,000. [determined by gel permeation chromatography].
  • Polyacrylates are also advantageously gelators to be used in the context of the present invention.
  • Polyacrylates which are advantageous according to the invention are acrylate-alkyl acrylate copolymers, in particular those selected from the group of the so-called carbomers or carbopols (Carbopol® is actually a registered trademark of B.F. Goodrich Company).
  • the acrylate copolymer (s) according to the invention are characterized by the following structure:
  • R ' represents a long-chain alkyl radical and x and y represent numbers which symbolize the respective stoichiometric proportion of the respective comonomers.
  • Particularly preferred according to the invention are acrylate copolymers and / or acrylate-alkyl acrylate copolymers, which are available under the trade names Carbopol® 1382, Carbopol® 981 and Carbopol® 5984 from the BF Goodrich Company.
  • the total amount of one or more thickeners in the finished cosmetic or dermatological preparations advantageously less than 1, 5 wt .-%, preferably between 0.1 and 1, 0 wt .-%, based on the total weight of the preparations selected.
  • the cosmetic or dermatological preparations may be composed as usual and used for the treatment, care and cleansing of the skin and / or the hair and as a make-up product in decorative cosmetics.
  • They preferably contain from 0.001% by weight to 10% by weight, preferably from 0.05% by weight to 5% by weight, in particular from 0.1% to 2.0% by weight, based on the total weight of the preparations, of folic acid and / or its derivatives.
  • Cosmetic and dermatological preparations according to the invention can be present in various forms.
  • they may contain a solution, an anhydrous preparation, an emulsion or microemulsion of the water-in-oil (W / O) type or of the oil-in-water (O / W) type, a multiple emulsion, for example water-type. in-oil-in-water (W / O / W), a gel, a solid stick, an ointment or even an aerosol.
  • folic acid and / or its derivatives in encapsulated form, for example in collagen matrices and other customary encapsulating materials, for example as encapsulated encapsulations, in gelatin, wax matrices or liposomally encapsulated.
  • wax matrices as described in DE-OS 43 08 282, have been found to be favorable.
  • the cosmetic and dermatological preparations according to the invention may comprise cosmetic adjuvants such as are conventionally used in such preparations, e.g. Preservatives, bactericides, perfumes, foaming inhibitors, colorants, pigments having a coloring effect, thickeners, surface-active substances, emulsifiers, softening, moistening and / or moisturizing substances, fats, oils, waxes or other conventional ingredients of a cosmetic or cosmetic dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
  • cosmetic adjuvants such as are conventionally used in such preparations, e.g. Preservatives, bactericides, perfumes, foaming inhibitors, colorants, pigments having a coloring effect, thickeners, surface-active substances, emulsifiers, softening, moistening and / or moisturizing substances, fats, oils, waxes or other conventional ingredients of a cosmetic or cosmetic dermatological formulation such as alcohol
  • folic acid and / or its derivatives can also be combined with other antioxidants and / or radical scavengers.
  • the amount of antioxidants (one or more compounds) in the preparations is preferably from 0.001 to 30% by weight, particularly preferably from 0.05 to 20% by weight, in particular from 1 to 10% by weight, based on the total weight of the preparation ,
  • the lipid phase can advantageously be selected from the following substance group: mineral oils, mineral waxes
  • Oils such as triglycerides of capric or caprylic acid, further natural oils such as e.g. Castor oil;
  • Fats, waxes and other natural and synthetic fats preferably esters of fatty acids with lower C-number alcohols, e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low C number or with fatty acids; benzoates;
  • Silicone oils such as dimethylpolysiloxanes, diethylpolysiloxanes, diphenylpolysiloxanes and mixed forms thereof.
  • the oil phase of the emulsions, oleogels or hydrodispersions or lipodispersions in the context of the present invention is advantageously selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 3 to 30 carbon atoms and saturated and / or or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms.
  • ester oils can then advantageously be selected from the group isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2 Octyldodecyl palmitate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate and also synthetic, semisynthetic and natural mixtures of such esters, eg jojoba oil.
  • the aqueous phase of the preparations according to the invention optionally advantageously contains alcohols, diols or polyols of low C number, and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or -mob nobutyl ether, propylene glycol monomethyl, -monoethyl- or -monobutylether , Diethylene glycol monomethyl or monoethyl ether and analogous products, furthermore lower C-number alcohols, eg Ethanol, isopropanol, 1, 2-propanediol, glycerol and in particular one or more thickening agents, which or which can be advantageously selected from the group of silica, aluminum silicates, polysaccharides or their derivatives, e.g.
  • Hyuronic acid, xanthan gum, hydroxypropylmethylcellulose particularly advantageously from the group of the polyacrylates, preferably a polyacrylate from the group of the so-called Carbopol, for example Carbopols types 980, 981, 1382, 2984, 5984, in each case individually or in combination.
  • Carbopol for example Carbopols types 980, 981, 1382, 2984, 5984, in each case individually or in combination.
  • mixtures of the abovementioned solvents are used.
  • alcoholic solvents water can be another ingredient.
  • Emulsions according to the invention are advantageous and contain, for example, the said fats, oils, waxes and other fatty substances, as well as water and an emulsifier, as is customarily used for such a type of formulation.
  • Gels according to the invention usually contain alcohols of low carbon number, for example ethanol, isopropanol, 1,2-propanediol, glycerol and water or an abovementioned oil in the presence of a thickener, which in the case of oily-alcoholic gels preferably silica or an aluminum silicate in aqueous-alcoholic or alcoholic gels is preferably a polyacrylate.
  • Suitable propellants for preparations which can be sprayed from aerosol containers according to the invention are the customary known highly volatile, liquefied propellants, for example hydrocarbons (propane, butane, isobutane), which can be used alone or mixed with one another. Also, compressed air is advantageous to use.
  • preparations according to the invention may also contain substances which absorb UV radiation in the UVB range, the total amount of filter substances being e.g. 0.1 wt .-% to 30 wt .-%, preferably 0.5 to 10 wt .-%, in particular 1, 0 to 6.0 wt .-%, based on the total weight of the preparations to cosmetic preparations for To provide the hair or the skin against the entire range of ultraviolet radiation. They can also serve as a sunscreen for hair or skin.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des préparations cosmétiques ou dermatologiques contenant de l'acide folique et/ou des dérivés d'acide folique, des matières de charge et des épaississants.
PCT/EP2007/005871 2006-07-13 2007-07-03 Préparations cosmétiques ou dermatologiques contenant de l'acide folique, des matières de charge et des épaississants WO2008006486A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07765018A EP2046272A1 (fr) 2006-07-13 2007-07-03 Préparations cosmétiques ou dermatologiques contenant de l'acide folique, des matières de charge et des épaississants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006032414.5 2006-07-13
DE102006032414A DE102006032414A1 (de) 2006-07-13 2006-07-13 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Folsäure, Füllstoffen und Verdickern

Publications (1)

Publication Number Publication Date
WO2008006486A1 true WO2008006486A1 (fr) 2008-01-17

Family

ID=38473036

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/005871 WO2008006486A1 (fr) 2006-07-13 2007-07-03 Préparations cosmétiques ou dermatologiques contenant de l'acide folique, des matières de charge et des épaississants

Country Status (3)

Country Link
EP (1) EP2046272A1 (fr)
DE (1) DE102006032414A1 (fr)
WO (1) WO2008006486A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012221224A1 (de) * 2012-11-20 2014-05-22 Beiersdorf Ag Hydrodispersion mit verbesserter Leistung
DE102012221227A1 (de) * 2012-11-20 2014-05-22 Beiersdorf Ag Sensorisch attraktive Hydrodispersion mit Wachsen

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2513879A1 (fr) * 1981-10-02 1983-04-08 Olivier Georges Compositions permettant de combattre les mefaits et les inconvenients de la transpiration
US4777034A (en) * 1982-04-01 1988-10-11 Olivier Georges R G Compositions for counteracting the degradations and inconvenience of perspiration
EP0311259A2 (fr) * 1987-09-14 1989-04-12 The Procter & Gamble Company Compositions buccales
DE4341001A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Topische Zubereitungen mit einem Gehalt an L-Arginin
EP1214927A1 (fr) * 2000-12-14 2002-06-19 Beiersdorf AG Utilisation de l' acide folique et/ou de ses dérivés pour la préparation de compositions topiques
EP1250915A1 (fr) * 2001-04-19 2002-10-23 Beiersdorf Aktiengesellschaft Compositions cosmetiques ou dermatologiques comprenant un contenu elevé des électrolytes
EP1609462A1 (fr) * 2004-04-22 2005-12-28 JUVENA (International) AG Préparation cosmétique ou dermatologique comprenant un milieu nutritif
WO2007014644A1 (fr) * 2005-08-01 2007-02-08 Beiersdorf Ag Combinaisons d'agents actifs stables a base d'acide folique
WO2007014643A1 (fr) * 2005-08-01 2007-02-08 Beiersdorf Ag Combinaisons d'agents actifs stables a base d'acide folique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10206159A1 (de) * 2002-02-14 2003-08-28 Kosmas Kg Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
DE102005001479A1 (de) * 2005-01-12 2006-07-20 Synavit Gmbh Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
DE102005009379A1 (de) * 2005-03-01 2006-09-07 Synavit Gmbh Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2513879A1 (fr) * 1981-10-02 1983-04-08 Olivier Georges Compositions permettant de combattre les mefaits et les inconvenients de la transpiration
US4777034A (en) * 1982-04-01 1988-10-11 Olivier Georges R G Compositions for counteracting the degradations and inconvenience of perspiration
EP0311259A2 (fr) * 1987-09-14 1989-04-12 The Procter & Gamble Company Compositions buccales
DE4341001A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Topische Zubereitungen mit einem Gehalt an L-Arginin
EP1214927A1 (fr) * 2000-12-14 2002-06-19 Beiersdorf AG Utilisation de l' acide folique et/ou de ses dérivés pour la préparation de compositions topiques
EP1250915A1 (fr) * 2001-04-19 2002-10-23 Beiersdorf Aktiengesellschaft Compositions cosmetiques ou dermatologiques comprenant un contenu elevé des électrolytes
EP1609462A1 (fr) * 2004-04-22 2005-12-28 JUVENA (International) AG Préparation cosmétique ou dermatologique comprenant un milieu nutritif
WO2007014644A1 (fr) * 2005-08-01 2007-02-08 Beiersdorf Ag Combinaisons d'agents actifs stables a base d'acide folique
WO2007014643A1 (fr) * 2005-08-01 2007-02-08 Beiersdorf Ag Combinaisons d'agents actifs stables a base d'acide folique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
K. SCHRADER, A. DOMSCH: "Cosmeticology - Theory and Practice", 2005, VERLAG FÜR CHEMISCHE INDUSTRIE, H. ZIOLKOWSKY GMBH, AUGSBURG, XP002450957 *

Also Published As

Publication number Publication date
DE102006032414A1 (de) 2008-01-17
EP2046272A1 (fr) 2009-04-15

Similar Documents

Publication Publication Date Title
EP1812116B1 (fr) Produit cosmetique absorbant la sueur et son procede de fabrication
US20050136079A1 (en) Cosmetic compositions containing fullerene clusters
JP5851726B2 (ja) 水中油型乳化メイクアップ化粧料
EP0930866A1 (fr) Gels cosmetiques ou dermatologiques a base de microemulsions
DE602004000784T2 (de) Kosmetische Zusammensetzung, enthaltend eine Polymerpartikeldispersion und einen Polyol-Säureester zur Dispergierung von Pigmenten
CN112656729A (zh) 一种控油隔离组合物及其制备方法与应用
US20240099955A1 (en) Skincare compositions and methods of use thereof
JP5006553B2 (ja) 改良された化粧品組成物
DE102006007831C5 (de) Vernetztes Kohlehydratpolymer, insbesondere auf Basis von Polysacchariden und/oder Oligosacchariden und/oder Polyolen
JP2006241012A (ja) 被覆粉体及びそれを含有してなる化粧料
KR20140090942A (ko) 중합체 입자들 및 낮은 수준의 점토를 포함하는 수성 조성물
EP1139980A1 (fr) Preparations cosmetiques ou medicales pour utilisation topique
EP2046272A1 (fr) Préparations cosmétiques ou dermatologiques contenant de l'acide folique, des matières de charge et des épaississants
JP7118634B2 (ja) 穀物の発酵生成物及びヘクトライトを含むｏ／ｗエマルションの形態の組成物
DE69918626T2 (de) Zusammensetzung zur äusserlichen Anwendung enthaltend Succinoglucan, Tonerde und ein Alkylacrylat/methacrylat Copolymer
JP3739971B2 (ja) 外用組成物
DE10034102A1 (de) Kosmetische oder dermatologische Zubereitungen in Form von Gelen, enthaltend Iminodibernsteinsäure
EP1882471A2 (fr) Préparation cosmétique comportant de l'acide folique et des composants parfumés
DE19860373B4 (de) Mundpflegemittel und Verwendung von sphärischen Mikropartikeln
JPH11292750A (ja) 化粧料
AU701917B2 (en) Topical preparations having a protective action against cnidaria
WO2008040463A1 (fr) Préparations cosmétiques ou dermatologiques comprenant de l'ester méthylique de l'acide (r)-2-[((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-propionique et une ou plusieurs matières de charge
JP2000355518A (ja) ゲル状化粧料
DE102006047159A1 (de) Kosmetische oder dermatologische Zubereitungen mit (R)-2-[((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-propionsäure ethyl ester und einem oder mehreren Füllstoffen
WO2023232570A1 (fr) Granules de particules antimicrobiennes à base d'argile

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07765018

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2007765018

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU